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here There’s Smoke. . .*
avid S. Celermajer, MBBS, DSC, FAA, FRACP,
artin K. C. Ng, MBBS, PHD, FRACP
ydney, Australia
nvironmental tobacco smoke (ETS) contains nicotine,
articulate matter, and a wide variety of potential biological
oxins, which epidemiological and mechanistic studies now
oherently suggest can be responsible for increased cardio-
ascular risk. Although many are surprised that the effects of
TS on cardiovascular risk rates are not too dissimilar from
he magnitude of risk conferred by active cigarette smoking,
TS is neither filtered nor burnt at as high temperatures as
ainstream smoke inhaled by the active smoker, and thus
lausibly has a different and potentially more hazardous
hemical composition, balancing the fact that the mass dose
f smoke experienced by passive compared to active smokers
s manifold lower.
See page 1760
Indeed, published epidemiologic studies are remarkably
onsistent in documenting cardiovascular event rates 20% to
0% higher in ETS-exposed versus nonexposed adults, with
he risk applying whether such exposure occurs in the home
r at work (1,2). In a remarkable recent study, Kallio et al.
3) even showed that tobacco smoke exposure was associated
ith impaired arterial endothelial function in healthy 11-
ear-old children.
A number of putative mechanisms have been studied to
xplain the link between ETS exposure and atherothrom-
otic risk. These include increased sympathetic activity,
nhanced platelet aggravation, and increased uptake of
xidatively damaged lipoprotein particles by foam cell mac-
ophages (4). Perhaps the most consistently observed vas-
ular consequence of ETS exposure is impairment of arterial
ndothelial function, measured as flow-mediated dilation
FMD) of the systemic arteries, a phenomenon in large part
aused by diminished nitric oxide release by the arterial
ndothelium. Endothelial dysfunction has now been shown
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iews of the authors and do not necessarily represent the views of JACC or the
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From the Department of Medicine, University of Sydney; Department of Cardi-c
logy, Royal Prince Alfred Hospital; and the Heart Research Institute, Sydney,
ustralia.n a large number of prospective studies to predispose to
linical cardiovascular events (5).
In recent years, it has become appreciated that endothelial
ysfunction is reversible by a number of potential interven-
ions, including physical exercise and lipid lowering. The
echanisms that underlie endothelial damage and repair are
ow being investigated with a new urgency, stimulated by a
ecent literature linking endothelial progenitor cells to
estoration of normal endothelial function (6) and to the
ole of endothelial progenitor cell (EPC) therapy in improv-
ng clinical outcomes in a variety of cardiovascular disorders.
he biology of EPCs, however, is complex, with a lack of
larity currently surrounding the definition of an EPC, how
o characterize EPCs ex vivo, and the different physio-
ogical functions of different types of EPCs in health and
isease (7,8).
In this context, the current findings of Heiss et al. (9)
oncerning a profound and sustained effect of brief exposure
o ETS on EPC numbers and function are disturbing. In
heir study reported in this issue of the Journal, the inves-
igators report that real-world levels of ETS exposure for
ust 30 min result in profound changes in vascular biology
ver the subsequent 24 h. There is a marked increase in
PC numbers, but these EPCs have importantly impaired
bility to migrate toward vascular endothelial growth factor
VEGF), a key signaling molecule in vascular growth and
epair. This impairment of EPC chemotaxis seems to be
ediated by a plasma factor, as yet unidentified, which
ecreases VEGF-stimulated nitric oxide production by the
PCs. The investigators also document an increase in
ndothelial microparticles circulating after ETS exposure
nd a significant decrease in flow-mediated dilation of the
rachial artery. Thus ETS exposure seems to result in a
ouble hit: acute endothelial injury as evidenced by the
ecrease in FMD and increase in endothelial microparticle
elease, and an impairment in the repair mechanism of
ndothelial damage, as the EPCs rapidly mobilized after
TS exposure are dysfunctional and possibly incapable of
estoring normal endothelial function.
Emerging data suggest that nicotine may play a key role
n some of the observed effects of ETS. Nicotine is known
o stimulate angiogenesis and to participate in tumor an-
iogenesis and atherosclerotic plaque neovascularization via
timulation of endothelial nicotinic acetylcholine receptors
nAChR) (10). Recent data suggest that EPCs participate
n nicotine-mediated angiogenesis. In mice, nicotine ad-
inistration increases EPC proliferation, mobilization, and
ncorporation into sites of ischemia-induced neovasculariza-
ion (11). Interestingly, nAChR stimulation also plays an
mportant role in VEGF-mediated endothelial cell migra-
ion and specific nAChR blockade substantially attenuates
he migragenic effects of VEGF (12). It is therefore plau-
ible that the observed ETS-mediated EPC mobilization is,
n part, mediated by nicotine via nAChR activation. Be-
ause nicotine improves EPC incorporation into new vessels
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May 6, 2008:1772–4 Editorial Commentn vivo, the observed effects of ETS on impairment of EPC
hemotaxis may be mediated by the additive effects of
otinine and other compounds rather than by nicotine.
evertheless, as acute nicotine exposure markedly down-
egulates nAChR (12), the activation of which is a key
ignaling event in VEGF-mediated migration, acute ETS
xposure may lead to impairment of the nAChR-dependent
echanisms for VEGF-dependent migration.
There are some excellent features in the study by Heiss
t al. (9), including the documentation that the ETS
xposure obtained in the custom-built glass chamber de-
cribed does indeed result in similar levels of nicotine and
articulate matter compared with those observed in bars and
estaurants where smoking is permitted, and resulted in
imilar cotinine levels in the nonsmokers compared with
hose observed in passive smokers in real-world situations.
he experiment was well controlled with the use of a
moke-free air control situation. Given current debate and
ncertainty over EPC definitions (7), the investigators are
o be commended for corroborating their cell surface anti-
en expression-derived (CD133/KDR and CD34/
DR) EPC counts with culture-based EPC assessment to
onfirm an increase in monocytic cells showing an endothe-
ial cell-like phenotype, because there is evidence to suggest
hat EPCs identified by flow cytometry are not the same as
he EPC subpopulations identified in culture.
Some limitations should also be noted. The number of
ubjects was very small (10 subjects attended for a first visit,
nd only 7 completed the schedule of 2 visits); because 5 key
nd points were measured (FMD, EPC numbers, EPC
unction, endothelial microparticles, and VEGF levels),
onfidence in the conclusions should be tempered by the
elatively small sample size. Furthermore, the pathophysio-
ogical relevance of endothelial microparticles remains un-
ertain, as noted by the investigators, and only 1 measure of
PC dysfunction has been provided (chemotaxis toward
EGF); further studies might examine other EPC func-
ions, such as ability to repair endothelial damage and
ngiogenic potential.
The current study has evaluated the acute effects of ETS
n EPC mobilization and function. However, the cumula-
ive effects of ETS might be different from the acute effects,
s has been noted in the case of mainstream smoke exposure
13). Although a study of 519 coronary artery disease
atients found that smoking was associated with increased
irculating CD34/KDR EPCs but impaired EPC func-
ion as determined by colony-forming assay (14), another
ecent study of 574 subjects from the general population
ound that neither smoking status nor dose of smoking
xposure had any significant association with culture-
erived EPC counts or EPC function using a similar
unctional assay (15). The discrepancy between these large
tudies may reflect, in part, different sensitivities to ETS
ffects in coronary artery disease versus healthy populations.
ecause different EPC definitions were used for counting in
he 2 studies, it is likely that inherent differences in cellopulations studied also played a role in the heterogeneity of
hese study findings. Further studies, using more robust
PC definitions, are required to elaborate the effects of
hronic ETS exposure on EPC function.
Thus, there seem to be 2 key “take-home messages” from
he current study. The first is that exposure to commonly
ncountered levels of ETS for short periods of time can have
rofound and sustained effects on several aspects of endo-
helial cell biology and thus arterial health, including micro-
article release, nitric oxide release, and dysfunction of
PCs, some or all of which may contribute to the important
ardiovascular risk of ETS exposure.
The second and perhaps more provocative message is the
mportance of measuring EPC function, as well as simple
PC numbers, in assessing reparative or therapeutic capa-
ilities of EPCs in pathophysiological situations. The ma-
ority of published studies on EPCs to date have simply used
PC numbers as indicators of effective cardiovascular repair
nd therapeutic potential. Nevertheless, ETS exposure pro-
ides a significant lesson in this regard; EPC numbers may
e high but their function may be poor, and this may lead to
dverse (or neutral) rather than beneficial consequences.
Some recent articles have started to examine the factors
ssociated with dysfunctional EPCs, and these include
ardiovascular risk factors in general (16) and the effects of
ge and coronary disease in particular. It is also unclear what
he process of ex vivo culture does to the ability to measure
PC function accurately, and this will be particularly impor-
ant in subsequent studies that examine the putative therapeu-
ic potential of EPCs.
Epidemiological and mechanistic studies concerning the
dverse cardiovascular effects of passive smoking have now
esulted in public health and legislative changes that have
rotected countless individuals from cardiovascular events;
his constitutes one of the great efforts of preventive medicine
f the last decade. Studies such as those by Heiss et al. (9) have
hown that where there’s smoke, there is indeed fire, a
ustained and complex adverse response that threatens
ardiovascular homeostasis with potentially important
ealth consequences. Among these, the concept that EPC
ysfunction, rather than simply number, may be a particu-
arly maladaptive cardiovascular response is an exciting and
rovocative one, worthy of much further investigation.
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